日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.

循环肿瘤细胞可预测对靶向 DLL3 的双特异性抗体 Tarlatamab 的反应。

Mishra Avanish, Meador Catherine B, Kikkeri Kruthika, Cunneely Quinn, Lin Maoxuan, Carmona-LaSalle Thomas J, Huang Shih-Bo, Bell Remy, Putaturo Victor, Xia Weikun, Liang Joyce H, Fang Jacy, San Vicente Sarah, Zielinski Caroline E, Digumarthy Subba R, Hung Yin P, Yeap Beow Y, Edd Jon F, Lawrence Michael S, Sade-Feldman Moshe, Sen Debattama R, Toner Mehmet, Maheswaran Shyamala, Gainor Justin F, Haber Daniel A

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS(G12C) inhibitors

具有黏液性组织学特征的肺腺癌:临床、基因组和免疫微环境特征以及基于免疫疗法和KRAS(G12C)抑制剂的治疗结果

Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; Alessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective Study

晚期ALK阳性非小细胞肺癌患者继续接受新一代ALK TKI联合化疗的疗效和安全性:一项多中心回顾性研究

Waliany, Sarah; Roy, Shambo Guha; Pecci, Federica; Weber, Urs M; Sun, Fangdi; Arter, Zhaohui; Lomibao, Meghanne; Alessi, Joao V; Nishino, Mizuki; Luo, Faustine; Repetto, Matteo; Falcon, Christina; Do, Andrew; Peterson, Jennifer; Liang, Joyce; Liu, Audrey; Nagasaka, Misako; Ricciuti, Biagio; Drilon, Alexander; Ou, S Ignatius; Neal, Joel W; Patil, Tejas; Awad, Mark; Yeap, Beow Y; Digumarthy, Subba R; Lin, Jessica J

Pretreatment Chest X-ray Scores and HIV Serostatus Are Associated with Lung Function at Tuberculosis Cure

治疗前胸部X光评分和HIV血清状态与结核病治愈时的肺功能相关

Nuwagira, Edwin; Baluku, Joseph Baruch; Bajunirwe, Francis; Siedner, Mark J; Digumarthy, Subba R; Kang, Jiyoon; Mpagama, Stellah G; Allwood, Brian W; Lai, Peggy S

Durvalumab Combined With Pemetrexed-Based Chemotherapy in Trial-Ineligible Patients With Mesothelioma: A Brief Report

在不适合临床试验的间皮瘤患者中,度伐利尤单抗联合培美曲塞化疗:简要报告

Dagogo-Jack, Ibiayi; Lasko, Aubrey; Krueger, Elizabeth A; Tsang, Kitman; Rao, Revati; Hambelton, Grace; Digumarthy, Subba R

Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies

具有潜在可靶向基因组改变的肺类癌肿瘤及其对靶向治疗的反应

Waliany, Sarah; Hung, Yin P; Rous, Fawzi Abu; Luo, Faustine; Capelletti, Marzia; Ressler, Steven; Do, Andrew; Peterson, Jennifer; Meservey, Caitlin; Digumarthy, Subba R; Ou, Sai-Hong Ignatius; Gadgeel, Shirish M; Lin, Jessica J; Meador, Catherine B

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

在接受标准剂量阿来替尼治疗后出现中枢神经系统复发的转移性ALK阳性非小细胞肺癌患者中,剂量递增的阿来替尼的疗效和安全性

Cheung, Justin M; Kang, Jiyoon; Yeap, Beow Y; Peterson, Jennifer L; Do, Andrew; Gainor, Justin F; Digumarthy, Subba R; Lin, Jessica J

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

晚期非小细胞肺癌中的共突变和KRASG12C抑制剂疗效

Negrao, Marcelo V; Araujo, Haniel A; Lamberti, Giuseppe; Cooper, Alissa J; Akhave, Neal S; Zhou, Teng; Delasos, Lukas; Hicks, J Kevin; Aldea, Mihaela; Minuti, Gabriele; Hines, Jacobi; Aredo, Jacqueline V; Dennis, Michael J; Chakrabarti, Turja; Scott, Susan C; Bironzo, Paolo; Scheffler, Matthias; Christopoulos, Petros; Stenzinger, Albrecht; Riess, Jonathan W; Kim, So Yeon; Goldberg, Sarah B; Li, Mingjia; Wang, Qi; Qing, Yun; Ni, Ying; Do, Minh Truong; Lee, Richard; Ricciuti, Biagio; Alessi, Joao Victor; Wang, Jing; Resuli, Blerina; Landi, Lorenza; Tseng, Shu-Chi; Nishino, Mizuki; Digumarthy, Subba R; Rinsurongkawong, Waree; Rinsurongkawong, Vadeerat; Vaporciyan, Ara A; Blumenschein, George R; Zhang, Jianjun; Owen, Dwight H; Blakely, Collin M; Mountzios, Giannis; Shu, Catherine A; Bestvina, Christine M; Garassino, Marina Chiara; Marrone, Kristen A; Gray, Jhanelle E; Patel, Sandip Pravin; Cummings, Amy L; Wakelee, Heather A; Wolf, Juergen; Scagliotti, Giorgio Vittorio; Cappuzzo, Federico; Barlesi, Fabrice; Patil, Pradnya D; Drusbosky, Leylah; Gibbons, Don L; Meric-Bernstam, Funda; Lee, J Jack; Heymach, John V; Hong, David S; Heist, Rebecca S; Awad, Mark M; Skoulidis, Ferdinandos

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

影响晚期非小细胞肺癌一线化疗免疫疗法疗效的临床病理及基因组因素

Alessi, Joao V; Elkrief, Arielle; Ricciuti, Biagio; Wang, Xinan; Cortellini, Alessio; Vaz, Victor R; Lamberti, Giuseppe; Frias, Rosa L; Venkatraman, Deepti; Fulgenzi, Claudia A M; Pecci, Federica; Recondo, Gonzalo; Di Federico, Alessandro; Barrichello, Adriana; Park, Hyesun; Nishino, Mizuki; Hambelton, Grace M; Egger, Jacklynn V; Ladanyi, Marc; Digumarthy, Subba; Johnson, Bruce E; Christiani, David C; Lin, Xihong; Gainor, Justin F; Lin, Jessica J; Pinato, David J; Schoenfeld, Adam J; Awad, Mark M